X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Under the partnership, Avanzanite gains commercialization and distribution rights into three additional European countries, for Sibnayal (potassium citrate and potassium bicarbonate), the first approved medicinal product in Europe for distal Renal Tubular Acidosis.
Lead Product(s): Potassium Citrate,Potassium hydrogen carbonate
Therapeutic Area: Nephrology Product Name: Sibnayal
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Advicenne
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership October 18, 2023
Details:
Sibnayal (potassium citrate) is a medicine used to treat patients from the age of one year with distal renal tubular acidosis (dRTA), a disease in which the kidneys do not remove acid through the urine well enough.
Lead Product(s): Potassium Citrate,Potassium hydrogen carbonate
Therapeutic Area: Nephrology Product Name: Sibnayal
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Advicenne
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement February 28, 2023
Details:
AKANTIOR® (polihexanide) is an investigational anti-amoebic polymer that has been granted Orphan Drug Designation by both the European Medicines Agency ("EMA") and Food and Drug Administration ("FDA") for AK.
Lead Product(s): Polyhexanide
Therapeutic Area: Infections and Infectious Diseases Product Name: Akantior
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: SIFI
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 10, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
